TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 14,848,809 | 11,153,233 | 10,687,920 |
Financial expenses | 136,858 | 45,566 | 99,925 |
Earnings before taxes | -1,856,708 | 2,251,024 | 3,598,605 |
EBITDA | 2,655,482 | 2,514,643 | 3,728,319 |
Total assets | 24,268,127 | 30,905,260 | 31,590,834 |
Current assets | 3,033,617 | 3,124,603 | 2,384,458 |
Current liabilities | 2,242,121 | 1,980,952 | 2,363,337 |
Equity capital | 19,006,335 | 25,573,898 | 26,072,500 |
- share capital | 184,574 | 200,843 | 204,633 |
Employees (average) | 6,875 | 6,814 | 6,633 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 78.3% | 82.7% | 82.5% |
Turnover per employee | 2,160 | 1,637 | 1,611 |
Profit as a percentage of turnover | -12.5% | 20.2% | 33.7% |
Return on assets (ROA) | -7.1% | 7.4% | 11.7% |
Current ratio | 135.3% | 157.7% | 100.9% |
Return on equity (ROE) | -9.8% | 8.8% | 13.8% |
Change turnover | 4,598,995 | 663,251 | 1,973,699 |
Change turnover % | 45% | 6% | 23% |
Chg. No. of employees | 61 | 181 | 483 |
Chg. No. of employees % | 1% | 3% | 8% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.